Eurofins Food Safety Systems Introduces BRC Certification Audits
Eurofins Food Safety Systems Introduces BRC Certification Audits
Des Moines, IA – December 1, 2015
Eurofins Food Safety Systems announces the expansion of BRC Global Food Certification Services into North America. Through their France-based accredited certification body (accreditation #5-0070, scope available on www.cofrac.fr), Eurofins is a world-wide provider of BRC certification audits. The US-based Food Safety Systems group can now offer local, qualified auditors to sites located in North America. The group issued its first BRC Certificate to a US supplier in November 2015. Eurofins is pleased to offer a global solution to companies seeking BRC certification.
BRC is a globally recognized, GFSI benchmarked certification standard that offers guidance to a wealth of industries including food, packaging, storage and distribution, consumer products, and agents and brokers. The BRC standard is well-known for its forward thinking and rigorous requirements that promotes consumer confidence and recognition for suppliers.
“We are increasing our global foot print and are committed to becoming the preferred provider in all aspects of food safety including testing, training, consulting, auditing and certification,” said Eurofins Food Safety Systems Director, Gary Smith. “We are pleased to expand our certification portfolio in order to meet the growing demands for BRC certification in the US, Canada, and Mexico.”
For more information, please visit www.eurofinsus.com/food-safety or contact:
Kim Knoll
Food Safety Systems
515-218-6933
Kimberlyknoll@eurofinsus.com
###
Eurofins Scientific is the world leader in food, environment and pharmaceutical products testing. It is also one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.
With 20,000 staff in around 200 laboratories across 38 countries, Eurofins offers a portfolio of over 130,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).